Table 2.
Baseline characteristics of the patients
| Characteristic | All Patients | Diabetic Patients | Nondiabetic Patients |
|---|---|---|---|
| Patients (n) | 329 | 133 | 196 |
| Men:women (n:n) | 165:164 | 74:59 | 91:105 |
| Age (yr)a | 59.8±12.3 | 64.6±9.8 | 56.5±12.7 |
| Body build | |||
| Height (cm) | 160.2±8.0 | 160.5±8.0 | 160.0±8.1 |
| Weight (kg)a | 62.1±12.4 | 66.0±12.5 | 59.4±11.6 |
| Body mass index (kg/m2)a | 24.1±3.9 | 25.5±3.5 | 23.1±3.9 |
| Waist circumference (cm)a | 90.3±10.8 | 95.3±9.7 | 86.9±10.1 |
| Hip circumference (cm)a | 96.4±8.2 | 99.3±8.1 | 94.5±7.7 |
| Waist-to-hip ratioa | 0.94±0.08 | 0.96±0.08 | 0.92±0.07 |
| Duration of dialysis (mo)a,b | 26.6 (13.3–57.0) | 21.9 (11.6–39.7) | 30.0 (14.6–66.2) |
| BP (mmHg) | |||
| Systolic | 141.0±22.0 | 143.1±23.5 | 139.5±20.8 |
| Diastolica | 75.3±12.0 | 71.2±11.2 | 78.1±11.7 |
| Diagnosis, n (%)a | |||
| GN | 104 (31.6) | 10 (7.5) | 94 (48.0) |
| Diabetes | 103 (31.3) | 103 (77.4) | 0 |
| Hypertension | 26 (7.9) | 6 (4.5) | 20 (10.2) |
| Polycystic | 15 (4.6) | 1 (0.8) | 14 (7.1) |
| Obstruction | 17 (5.2) | 2 (1.5) | 15 (7.7) |
| Others/unknown | 64 (19.5) | 11 (8.3) | 53 (27.1) |
| Major comorbidity | |||
| Diabetes, n (%)a | 133 (40.4) | 133 (100) | 0 |
| Coronary heart disease, n (%)a | 61 (18.5) | 39 (29.3) | 22 (11.2) |
| Cerebrovascular disease, n (%)a | 70 (21.3) | 41 (30.8) | 29 (14.8) |
| Charlson comorbidity index score | 5.6±2.6 | 7.6±2.1 | 4.2±1.9 |
Values expressed with a plus/minus sign are the mean±SD.
a
Significant difference between diabetic and nondiabetic patients.
b
Data presented as median (interquartile range).